首页> 外国专利> In vitro method to inhibit the function and / or proliferation of a janus tyrosine kinase 3, in vitro test method to assist in the identification of substances that are useful as therapeutic immunosuppressants, in vitro method to assist in the identification of a new immunosuppressant drug, in vitro to inhibit the function and / or proliferation of a cell expressing janus tyrosine kinase 3, use of at least one compound, isolated or purified chemical compound and pharmaceutical composition

In vitro method to inhibit the function and / or proliferation of a janus tyrosine kinase 3, in vitro test method to assist in the identification of substances that are useful as therapeutic immunosuppressants, in vitro method to assist in the identification of a new immunosuppressant drug, in vitro to inhibit the function and / or proliferation of a cell expressing janus tyrosine kinase 3, use of at least one compound, isolated or purified chemical compound and pharmaceutical composition

机译:抑制janus酪氨酸激酶3的功能和/或增殖的体外方法,辅助鉴定可用作治疗性免疫抑制剂的物质的体外试验方法,辅助鉴定新的免疫抑制剂药物的体外方法,在体外抑制表达janus酪氨酸激酶3的细胞的功能和/或增殖,使用至少一种化合物,分离或纯化的化合物和药物组合物

摘要

"IN VITRO METHOD TO INHIBIT THE FUNCTION AND / OR PROLIFERATION OF A TYROSOS KINASE 3 JANUARY, IN VITRO TEST METHOD TO HELP IDENTIFICATION OF SUBSTANCES THAT ARE USEFUL AS IMUNOSPHERE THERAPEUTIC IMPUNIUS IMUNOSUPRESSORS, IN VITRO METHOD FOR INHIBITING THE FUNCTION AND / OR PROLIFERATION OF A CELL BY EXPRESSING JANUS TYROSIN KINASE 3, USE AT LEAST ONE COMPOUND, ISOLATED OR PURIFIED CHEMICAL COMPOUND, AND PHARMACEUTICAL COMPOSITION ". Methods for inhibiting or disrupting function-dependent Janus tyrosine kinase 3 (Jak3) are described, especially for blocking lymphotic proliferation and function (eg, T-cells, B-cells). . A Mannich base compound, or derivative or modified compound, which is capable of selectively inhibiting Jak3, while affecting other protein tyrosine kinase activities to a lesser extent or not at all, is employed to provide beneficial effects such as rejection mitigation. transplantation and relief of allergic responses, with fewer side effects than with conventional immunosuppressive agents.
机译:“ 1月3日抑制酪氨酸激酶功能和/或增殖的体外方法,可用于鉴定可作为免疫治疗用不当免疫抑制剂的物质的体外测试方法,或抑制/启动或抑制功能的体外方法通过表达JANUS酪氨酸激酶3细胞,使用至少一种化合物,分离或纯化的化学化合物以及药物组合物”。描述了抑制或破坏功能依赖性Janus酪氨酸激酶3(Jak3)的方法,特别是用于阻断淋巴增殖和功能(例如T细胞,B细胞)的方法。 。能够选择性抑制Jak3,同时以较小程度或完全不影响其他蛋白质酪氨酸激酶活性的曼尼希碱化合物,或衍生物或修饰的化合物用于提供有益效果,例如缓解排斥反应。移植和减轻过敏反应,与传统的免疫抑制剂相比,副作用更少。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号